2023-04-19 06:15:17 ET
- HippoFi's ( OTCPK:ORHB ) unit Pur Biologics said it was issued a US patent for a technology which activates immune cells.
- The issued patent launches Pur into the field of cell and immune therapies, the company added.
- "By activating immune cells, we can unlock their full potential and create therapies that are more effective than ever before. PUR Biologics' innovative approach to utilizing this technology has the promise to improve the quality of life, particularly in our aging population," said Ryan Fernan, head of Pur.
For further details see:
Pur Biologics gets US patent linked to activating immune cells